European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading

MT Newswires Live
2024/09/12

European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading

European equities traded in the US as American depositary receipts were treading water late Thursday morning, nudging 0.1% lower to 1,424.33 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by internet browser company Opera (OPRA) and internet ad agency Criteo (CRTO), which rose 2.8% and 2%, respectively. They were followed by Sequans Communications S.A. (SQNS) and biopharmaceutical company Cellectis (CLLS), which were up 1.7% and 1.3%, respectively.

The decliners from continental Europe were led by furniture maker Natuzzi (NTZ) and biotech firm Evaxion Biotech (EVAX), which fell 6% and 3% respectively. They were followed by biotech firm BioNTech (BNTX) and biopharmaceutical company Grifols (GRFS), which were up 2.7% and 2.3%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company TC Biopharm (TCBP) and cruise line operator Carnival (CUK), which advanced 16% and 3.7%, respectively. They were followed by alcoholic beverage company Diageo (DEO) and biopharmaceutical company Bicycle Therapeutics (BCYC), which increased 2.6% each.

The decliners from the UK and Ireland were led by biotech firm Autolus Therapeutics (AUTL) and biopharmaceutical company Amarin (AMRN), which fell 2.8% and 2%, respectively. They were followed by biopharmaceutical company Mereo BioPharma Group (MREO) and pharmaceutical company AstraZeneca (AZN), which were down 1.7% each.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10